We are live on ! Find out more

37 hedge funds and large institutions have $8.54M invested in Imunon in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more call options, than puts

Call options by funds: $231K | Put options by funds: $112K

0% more funds holding

Funds holding: 3737 (0)

0% more ownership

Funds ownership: 0.05%0.05% (+0%)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

26% less capital invested

Capital invested by funds: $11.5M → $8.54M (-$2.95M)

Holders
37
Holders Change
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
7
Reduced
9
Closed
7
Calls
$231K
Puts
$112K
Net Calls
+$119K
Net Calls Change
+$97K

IMNN Hedge Fund Activity: Q3 2021 in Review

37 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2021, worth a combined $8.54M — down 26% from $11.5M a quarter earlier.

Fund positioning in IMNN was balanced in Q3 2021: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 9 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $764K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $431K sold.

  • 37 institutional investors held Imunon (IMNN) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $8.54M of Imunon stock for Q3 2021, down 26% quarter-over-quarter.
  • 7 funds opened new Imunon positions in Q3 2021 and 7 closed out, a net change of 0 holders.
  • The largest Imunon buyer in Q3 2021 was Morgan Stanley, an estimated $764K added.
  • The largest Imunon seller in Q3 2021 was Renaissance Technologies, an estimated $431K sold.

Based on aggregated 13F filings for Q3 2021.